The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRSA.L Share News (RSA)

  • There is currently no data for RSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-The new "win-win" market narrative

Fri, 06th Nov 2020 10:33

* Biden takes the lead in Georgia-CNN

* European shares end week rally

* STOXX 600 down 0.8%

* U.S futures fall

* Richemont shares surge after results

*
Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

A NEW "WIN-WIN" MARKET NARRATIVE (1033 GMT)

Analysts at Barclays admit they had not anticipated the
European stocks' rally after early vote counts showed the blue
wave, anticipated by polls, was out of the picture.

Equities "have been surprisingly prompt to cheer the new
post election paradigm that could see Biden facing a split
Congress," Barclays say.

Why is that?

"The new market narrative seems to be that gridlock reduces
the chances of a large scale stimulus, but may force the Fed to
step up QE, while also lowering the risk of market-unfriendly
progressive policies (e.g. tax hike, tighter regulation) being
implemented".

Anyhow, uncertainty is markets' number one enemy, so it
won't come as a surprise that what most stock investors really
want right now is a clear win for the U.S. election, regardless
who takes the job.

A "decisive win from either of the two candidates is more
important for markets in the near term, than who that winner
is," Barclays analysts added.

(Joice Alves)

*****

EUROPE’S STOCKS EDGE LOWER AFTER A STRONG WEEK (0838 GMT)

European stocks are slightly lower after a weak start of the
day as Italy and France registered record numbers of COVID-19
cases. Pandemic worries were, however, partly offset by a batch
of stronger than expected results.

The STOXX 600 is now down 0.4% and set to post its best week
since June as of now, with insurers outperforming up 0.6% after
Allianz reported an unexpected rise in Q3 profit.

Travel and leisure stock and tech stock
indexes are the worst performers respectively down 1% and 0.9%.

In terms of single stocks, Richemont shares are up
10% after the company said it sees a marked improvement in the
second quarter thanks to online retail sales and China.

(Stefano Rebaudo)

*****

ON THE RADAR: ALLIANZ, RICHEMONT, RSA (0740 GMT)

European stocks are poised to open lower after a 5-day rally
as focus is back on the economic impact of the virus, while
investors are waiting for final results of the U.S. elections.

Yet, a batch of stronger than expected corporate results is
providing some support to European equities.

Allianz stocks are up 2.1% in premarket trade
after the company posted an unexpected 6% rise in net profit in
the third quarter, at 1.947 billion euros, higher than 1.626
billion euro consensus forecast.

Shares in Richemont are indicated up 4% as the
company sees a marked improvement in the second quarter thanks
to online retail sales and China. The Cartier jewellery maker's
net profit fell 82% in the six months to Sept. 30.

On the back of Richemont, Swatch shares are up 2.75%
in premarket trade.

Freenet, Rheinmetall and Deutsche
Telekom shares are up respectively 1.6%, 1.8% and
1.9% after results.

Bullish news also on the M&A front, with RSA Insurance Group
in talks with a consortium of Canadian insurer Intact
Financial and Danish insurer Tryg about a
possible break-up deal that values the British firm at about 7.2
billion pounds ($9.46 billion).

Shares in Bilfinger are up 9.8% in premarket trade
on a press report that the company decided to explore a sale
after receiving takeover interest.

British industrial software provider Aveva Group
intends to raise 2.84 billion pounds through a rights issue to
partly fund the acquisition of SoftBank-backed peer OSIsoft.

In the vaccine front, AstraZeneca plans to start
early and mid-stage clinical trials of its COVID-19 vaccine
candidate in China this year as it prepares a global rollout.

Novartis's canakinumab failed to help COVID-19
patients survive without invasive ventilation compared with
standard therapy, dashing hopes the arthritis drug could be
repurposed during the pandemic.

Seven municipalities in northern Denmark imposed a hard
lockdown, while Britain said it is removing Denmark
from the government's travel corridor list. Paris
will be placed under more restrictions, Greece
ordered a nationwide lockdown for three weeks.

As a result, British airline easyJet said it will
fly no more than 20% of capacity for the rest of the year.

(Stefano Rebaudo and Joice Alves)

*****

EUROPE IN THE RED AFTER 5-DAY WINNING STREAK (0633 GMT)

European stock futures are in the red along with their U.S.
peers after a 5-day rally, but an expected political gridlock in
the U.S. props up risk sentiment.

Investors have been betting on a Republican controlled
Senate that would block any moves to tighten regulation and
raise taxes.

But their focus is now back on the economic impact of new
lockdowns in Europe to contain the pandemic and a U.S. fiscal
stimulus which could be way smaller than expected.

In the battleground states of Georgia and Pensylvania there
is not a clear winner of the presidential elections yet.

(Stefano Rebaudo)

*****

More News
5 Nov 2020 07:20

Insurer RSA says underwriting profit strongly higher in 2020

LONDON, Nov 5 (Reuters) - British insurer RSA said on Thursday its underwriting profit rose strongly in the first nine months of 2020 due to improvements it had made to its underwriting strategy, despite the impact of the COVID-19 pandemic.RSA's ...

Read more
3 Nov 2020 09:38

UK BROKER RATINGS SUMMARY: Morgan Stanley Raises BP And Shell

UK BROKER RATINGS SUMMARY: Morgan Stanley Raises BP And Shell

Read more
2 Nov 2020 18:24

UPDATE 2-UK regulator, insurers, set for November court battle over COVID-19 case

(Adds Financial Conduct Authority comment)By Kirstin Ridley and Carolyn CohnLONDON, Nov 3 (Reuters) - The UK Supreme Court will hear an appeal on Nov. 16 of the Financial Conduct Authority's (FCA) test case over which insurance companies should off...

Read more
2 Nov 2020 18:24

UPDATE 1-UK regulator, insurers, set for November court battle over COVID-19 case

(Adds detail, background)LONDON, Nov 2 (Reuters) - The UK Supreme Court will hear an appeal on Nov. 16 of the Financial Conduct Authority's (FCA) test case over which insurance companies should offer payouts to small businesses battered by the cor...

Read more
2 Nov 2020 17:20

UK Supreme Court to hear business interruption insurance appeal this month

LONDON, Nov 2 (Reuters) - The UK's Supreme Court will hear an appeal of the Financial Conduct Authority's (FCA) business interruption insurance test case from Nov 16, 2020, it said on Monday.The hearing is expected to last four days, the court sai...

Read more
29 Oct 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
21 Oct 2020 15:16

Insurers drop appeal against UK COVID-19 payout ruling on three policies

* Could lead to payouts to hundreds of struggling firms* Insurers to pursue appeal on two further policies* Lawyers for policyholders claim significant victoryBy Sinead CruiseLONDON, Oct 21 (Reuters) - Six insurers have decided not to appeal against...

Read more
18 Oct 2020 19:33

RSA chairman Martin Scicluna to step down next year - Sky News

Oct 18 (Reuters) - British insurance group RSA's chairman Martin Scicluna is expected to step down next year, Sky News reported on Sunday, citing sources. The Sky News report said RSA had begun a search for a successor to Scicluna, who also chair...

Read more
2 Oct 2020 17:15

UPDATE 2-FCA insurance test case appeal heads to Supreme Court

* Supreme Court to consider fast-tracked case by year-end* Qatar's QIC Europe fails in bid to join the proceedings* Appeal spells "nail in coffin" for small businesses-lawyer (Adds comment from small business, QIC Europe intervention attempt, lawye...

Read more
2 Oct 2020 17:15

UPDATE 1-London court fast-tracks FCA insurance test case appeal to Supreme Court

(Adds details, background)By Kirstin Ridley and Carolyn CohnLONDON, Oct 2 (Reuters) - London's High Court on Friday approved a fast-track appeal of an unprecedented test case against some of the world's biggest insurers, brought by Britain's marke...

Read more
2 Oct 2020 16:55

London court fast-tracks FCA insurance test case appeal to Supreme Court

LONDON, Oct 2 (Reuters) - London's High Court on Friday approved a fast-track appeal of an unprecedented test case against some of the world's biggest insurers, brought by Britain's markets regulator, allowing it to leapfrog straight into the Sup...

Read more
30 Sep 2020 17:44

UPDATE 2-UK regulator, insurers, brace for Supreme Court battle over COVID-19 case

(Adds details)By Kirstin Ridley and Carolyn CohnLONDON, Sept 30 (Reuters) - Britain's markets regulator said on Wednesday it had failed to strike a deal with major insurers over prompt payouts to small businesses battered by the coronavirus pandem...

Read more
30 Sep 2020 17:44

UPDATE 1-UK regulator, insurers, brace for Supreme Court battle over COVID-19 case

(Adds FCA comments, details, background)By Kirstin Ridley and Carolyn CohnLONDON, Sept 30 (Reuters) - Britain's markets regulator said on Wednesday it had failed to strike a deal with major insurers over prompt payouts to small businesses battered ...

Read more
29 Sep 2020 09:40

Appeals Lodged But UK Business Interruption Insurance Talks Continue

Appeals Lodged But UK Business Interruption Insurance Talks Continue

Read more
29 Sep 2020 09:37

UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo

UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.